SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-043606
Filing Date
2022-04-07
Accepted
2022-04-07 16:01:33
Documents
12
Period of Report
2022-04-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2212195d1_8ka.htm   iXBRL 8-K/A 44325
  Complete submission text file 0001104659-22-043606.txt   222889

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avdl-20220404.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20220404_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20220404_pre.xml EX-101.PRE 22591
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2212195d1_8ka_htm.xml XML 4111
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37977 | Film No.: 22813841
SIC: 2834 Pharmaceutical Preparations